These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26126915)
1. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology. Dal Corso A; Pignataro L; Belvisi L; Gennari C Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
3. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide. Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977 [TBL] [Abstract][Full Text] [Related]
7. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer. Sani S; Messe M; Fuchs Q; Pierrevelcin M; Laquerriere P; Entz-Werle N; Reita D; Etienne-Selloum N; Bruban V; Choulier L; Martin S; Dontenwill M Chembiochem; 2021 Apr; 22(7):1151-1160. PubMed ID: 33140906 [TBL] [Abstract][Full Text] [Related]
8. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors. Arosio D; Manzoni L; Corno C; Perego P Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756 [TBL] [Abstract][Full Text] [Related]
9. RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation. Wu H; Jiang J; Xu H; Li Q; Cai J Expert Opin Ther Pat; 2016; 26(1):131-7. PubMed ID: 26560186 [TBL] [Abstract][Full Text] [Related]
10. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Temming K; Schiffelers RM; Molema G; Kok RJ Drug Resist Updat; 2005 Dec; 8(6):381-402. PubMed ID: 16309948 [TBL] [Abstract][Full Text] [Related]
11. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index. Paulus J; Nachtigall B; Meyer P; Sewald N Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662 [TBL] [Abstract][Full Text] [Related]
12. Ligands for mapping alphavbeta3-integrin expression in vivo. Schottelius M; Laufer B; Kessler H; Wester HJ Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579 [TBL] [Abstract][Full Text] [Related]
13. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating. Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759 [TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD and Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382 [TBL] [Abstract][Full Text] [Related]
15. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand. Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617 [TBL] [Abstract][Full Text] [Related]
16. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related]
17. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404 [TBL] [Abstract][Full Text] [Related]
18. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment. Paulus J; Sewald N J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900 [TBL] [Abstract][Full Text] [Related]
19. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
20. Conjugates of a novel 7-substituted camptothecin with RGD-peptides as α(v)β₃ integrin ligands: An approach to tumor-targeted therapy. Dal Pozzo A; Esposito E; Ni M; Muzi L; Pisano C; Bucci F; Vesci L; Castorina M; Penco S Bioconjug Chem; 2010 Nov; 21(11):1956-67. PubMed ID: 20949910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]